Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Gynecol Oncol. 2020 Jun 11;158(3):570–575. doi: 10.1016/j.ygyno.2020.05.682

Figure 1:

Figure 1:

Waterfall plot illustrating response to pembrolizumab in 5 evaluable patients with cervical cancer. Two patients (1 with vulvar cancer and 1 with cervical cancer) had clinical progression before first imaging assessment and are not included in this figure.